ADAM23 negatively modulates αvβ3 integrin activation during metastasis

作者: Newton V. Verbisck , Érico T. Costa , Fabrício F. Costa , Felícia P. Cavalher , Michele D.M. Costa

DOI: 10.1158/0008-5472.CAN-08-2976

关键词:

摘要: AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO PARP, a nuclear enzyme that detects and binds to DNA single-strand breaks (SSBs), functions as an important modulator of base excision repair (BER). PARP is also involved in cellular recovery from ionizing radiation (IR)-induced damage by initiating signaling network responsible for the preservation genomic stability. protects SSBs induced deteriorating into more deleterious double-strand (DSB) during replication. As result, inhibitors are being developed cancer therapy due their ability sensitize cells DNA-damaging agents. The purpose this study was determine whether MK-4827, novel PARP-1 PARP-2 inhibitor Merck & Co., Inc., enhances radiosensitivity two NSCLC cell lines, A549 (p53 wild type) H1299 null). We examined effect MK-4827 on clonogenic survival showed 1-hour pretreatment followed 24-hour post-radiation treatment with 1 \#956;M substantially increased (Dose Enhancement Factor (DEF) 1.3) lesser extent (DEF = 1.15). Results analysis DSB demonstrated significantly number radiation-induced DSBs, detected basis \#947;-H2AX foci, at early times after irradiation compared only controls. However, measurement activity, based incorporation biotinylated poly(ADP-ribose) onto histone proteins, dramatically reduced enzymatic activity both lines within hour. Overall, we conclude inhibiting BER pathway compromised, leading conversion detrimental which ultimately results enhanced death. Reasons explain differences response between not understood time but may be difference p53 status or our observation typically have smaller proportion S-phase cells. Citation Information: In: Proc Am Assoc Cancer Res; 2009 18-22; CO. Philadelphia (PA): AACR; 2009. Abstract nr 5546.

参考文章(40)
Tanja Schneider, Franz Osl, Thomas Friess, Hubertus Stockinger, Werner V. Scheuer, Quantification of human Alu sequences by real-time PCR – an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants Clinical & Experimental Metastasis. ,vol. 19, pp. 571- 582 ,(2002) , 10.1023/A:1020992411420
Brunhilde Felding-Habermann, Diana Giannarelli, Pier Giorgio Natali, Massimo Temponi, Soldano Ferrone, Franco Di Filippo, Maria R. Nicotra, Carl V. Hamby, Bitao Liang, Clinical Significance of αvβ3 Integrin and Intercellular Adhesion Molecule-1 Expression in Cutaneous Malignant Melanoma Lesions Cancer Research. ,vol. 57, pp. 1554- 1560 ,(1997)
Richard O. Hynes, Integrins: Bidirectional, Allosteric Signaling Machines Cell. ,vol. 110, pp. 673- 687 ,(2002) , 10.1016/S0092-8674(02)00971-6
Steven M. Albelda, Laszlo Damjanovich, Meenhard Herlyn, Clayton A. Buck, David E. Elder, Stephen A. Mette, RoseMary Stewart, Integrin Distribution in Malignant Melanoma: Association of the β3 Subunit with Tumor Progression Cancer Research. ,vol. 50, pp. 6757- 6764 ,(1990)
Koji SAGANE, Yukio OHYA, Yoshikazu HASEGAWA, Isao TANAKA, Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain Biochemical Journal. ,vol. 334, pp. 93- 98 ,(1998) , 10.1042/BJ3340093
A.J. Docherty, G. Murphy, P.M. Slocombe, D. Nath, A. Webster, P.E. Stephens, Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1 )integrin, leading to a marked induction of fibroblast cell motility. Journal of Cell Science. ,vol. 113, pp. 2319- 2328 ,(2000) , 10.1242/JCS.113.12.2319
Gerald J. Mizejewski, Role of Integrins in Cancer: Survey of Expression Patterns Experimental Biology and Medicine. ,vol. 222, pp. 124- 138 ,(1999) , 10.1046/J.1525-1373.1999.D01-122.X
Satsuki Mochizuki, Yasunori Okada, ADAMs in cancer cell proliferation and progression Cancer Science. ,vol. 98, pp. 621- 628 ,(2007) , 10.1111/J.1349-7006.2007.00434.X
C. Thomssen, F. Jänicke, N. Harbeck, Clinical Relevance of Prognostic Factors in Axillary Node-Negative Breast Cancer Onkologie. ,vol. 26, pp. 438- 445 ,(2003) , 10.1159/000072976
Hisashi Takada, Issei Imoto, Hitoshi Tsuda, Yukihiro Nakanishi, Takashi Ichikura, Hidetaka Mochizuki, Shoji Mitsufuji, Fumie Hosoda, Setsuo Hirohashi, Misao Ohki, Johji Inazawa, ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation Oncogene. ,vol. 24, pp. 8051- 8060 ,(2005) , 10.1038/SJ.ONC.1208952